Free Trial

Voyager Therapeutics (VYGR) SEC Filings & 10K Form

Voyager Therapeutics logo
$3.30 -0.30 (-8.33%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$3.36 +0.06 (+1.67%)
As of 06/13/2025 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Voyager Therapeutics SEC Filings

DateFilerForm TypeView
06/04/2025
7:59 PM
GERAGHTY JAMES A (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
8:00 PM
Higgins Michael J (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
8:02 PM
Hyman Steven (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
8:03 PM
MACKEY CATHERINE J (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
8:04 PM
Onyia Jude (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
8:07 PM
PIERCE GLENN (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
8:08 PM
SCANGOS GEORGE A (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
8:09 PM
Vitale Nancy (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
7:58 PM
Colon Grace (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
2:22 PM
ARMISTICE CAPITAL, LLC (Filed by)
Voyager Therapeutics (Subject)
Form SCHEDULE 13G/A
04/24/2025
8:12 AM
BlackRock, Inc. (Filed by)
Voyager Therapeutics (Subject)
Form SCHEDULE 13G/A
04/23/2025
3:01 PM
Voyager Therapeutics (Filer)
Form DEF 14A
04/23/2025
3:02 PM
Voyager Therapeutics (Filer)
Form DEFA14A
04/23/2025
3:02 PM
Voyager Therapeutics (Filer)
Form ARS
02/24/2025
3:19 PM
Swartz Robin (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
3:20 PM
Sandrock Alfred (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
3:21 PM
Carter Todd Alfred (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:32 PM
Sandrock Alfred (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2025
3:21 PM
Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
4:24 PM
ARMISTICE CAPITAL, LLC (Filed by)
Voyager Therapeutics (Subject)
Form SCHEDULE 13G/A
02/12/2025
3:19 PM
Fahey Sandell Jacquelyn (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:20 PM
Sandrock Alfred (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:21 PM
Swartz Robin (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:22 PM
Carter Todd Alfred (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
2:36 PM
Swartz Robin (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/11/2025
2:37 PM
Sandrock Alfred (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/11/2025
2:40 PM
Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/11/2025
2:44 PM
Fahey Sandell Jacquelyn (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/11/2025
6:07 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
3:17 PM
Carter Todd Alfred (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:18 PM
Swartz Robin (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
2:14 PM
Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2025
2:17 PM
Swartz Robin (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2024
3:29 PM
Swartz Robin (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
10:31 AM
Swartz Robin (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
5:13 PM
EcoR1 Capital, LLC (Filed by)
Voyager Therapeutics (Subject)
Form SC 13G/A
09/05/2024
7:06 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
3:10 PM
Jorgensen Nathan D. (Reporting)
Voyager Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/09/2024
3:11 PM
Jorgensen Nathan D. (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VYGR) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners